| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $305.1M | +100.0% |
| Cost of Revenue | $96.7M | +34.9% |
| Gross Profit | $208.5M | +157.6% |
| R&D Expense | $49.4M | +34.9% |
| SG&A Expense | $143.1M | +56.4% |
| Operating Income | $16.0M | +134.0% |
| Pre-tax Income | $7.8M | +118.7% |
| Income Tax | $305K | +951.7% |
| Net Income | $7.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $496.0M | +159.0% |
| Accounts Receivable | $41.6M | +68.4% |
| Inventory | $17.5M | +100.9% |
| Current Assets | $560.6M | +146.1% |
| Total Assets | $632.7M | +109.4% |
| Current Liabilities | $48.0M | +69.0% |
| Long-term Debt | $57.2M | +11.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.6M | +159.4% |
| Capital Expenditures | $8.9M | +64.4% |
| Investing Cash Flow | -$8.9M | -64.2% |
| Financing Cash Flow | $288.8M | +104.8% |
| Free Cash Flow | $15.7M | +133.6% |
| +117.9% |
| EPS (Basic) | $0.18 | +104.4% |
| EPS (Diluted) | $0.14 | +103.4% |
| Total Liabilities |
| $152.5M |
| +13.6% |
| Stockholders' Equity | $480.1M | +290.8% |